Skip to main content

Beatriz Lobo Alvarez

Institutions of which they are part

Main researcher
Physiology and Pathophysiology of the Digestive Tract
Vall Hebron Institut de Recerca

Beatriz Lobo Alvarez

Institutions of which they are part

Main researcher
Physiology and Pathophysiology of the Digestive Tract
Vall Hebron Institut de Recerca

Projects

Efecto de la estabilización prolongada del mastocito intestinal con cromoglicato disódico en la evolución clínica y la microinflamación de la mucosa intestinal en los pacientes con síndrome de intestino irritable tipo diarrea

IP: Fco Javier Santos Vicente
Collaborators: Beatriz Lobo Alvarez, Mar Guilarte Clavero, Inés de Torres Ramirez, Cristina Martínez Martínez
Funding agency: Instituto de Salud Carlos III
Funding: 168190
Reference: EC07/90148
Duration: 01/11/2007 - 30/12/2011

CIBER Enfermedades hepáticas y digestivas (CIBEREHD)

IP: CIBER Enfermedades hepáticas y digestivas (CIBEREHD)
Collaborators: Beatriz Lobo Alvarez, Carmen Alonso Cotoner, Carolina Malagelada Prats, Jorge Serra Pueyo
Funding agency: CIBER Enfermedades Hepáticas y Digestivas
Funding:
Reference: CB06/04/0021
Duration: 01/01/2007 - 31/12/2010

Estudio de vías oxidativas facilitadoras del desarrollo de pancreatitis crónica.

IP: -
Collaborators: Beatriz Lobo Alvarez, María Antolín Mate
Funding agency: Instituto de Salud Carlos III
Funding: 81316.94
Reference: 01/1401
Duration: 17/07/2001 - 31/12/2003

Neurofisiología y Neurofisiopatología digestiva

IP: Neurofisiología y Neurofisiopatología digestiva
Collaborators: Beatriz Lobo Alvarez, Carolina Malagelada Prats, Ana Maria Gonzalez Castro
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 133100
Reference: SAF2006-03907
Duration: 01/10/2006 - 30/09/2009

Ministerio de Ciencia

Related news

A new diagnostic algorithm has been created to guide professionals in cases of persistent vomiting for more than four weeks.

Among the genes described, there are some related to digestive system functions, which reinforces the biological entity of irritable bowel syndrome as a digestive disease.

The international study, in which Vall d'Hebron participated, monitored patients who were hospitalized for COVID-19 for 12 months and compared their gastrointestinal symptoms with another group of patients diagnosed with other medical pathologies.

Related professionals

Ana Lain Fernandez

Ana Lain Fernandez

Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more
Ajla Idrizovic

Ajla Idrizovic

Research technician
Childhood Cancer and Blood Disorders
Read more
Mercedes Velasco Zarzuelo

Mercedes Velasco Zarzuelo

Research Group of Physical Medicine and Rehabilitation
Read more
Aitana Diaz Vazquez

Aitana Diaz Vazquez

Research technician
Clinical and Translational Bioinformatics
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.